trixeo aerosphere
astrazeneca ab - formoterol fumarate dihydrate, glycopyrronium bromide, budesonide - plućna bolest, kronična opstruktivna - lijekovi za opstruktivne plućne bolesti dišnih putova, - trixeo aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long acting beta2 agonist or combination of a long-acting beta2 agonist and a long acting muscarinic antagonist.
cortiment mmx 9 mg tablete s produljenim oslobađanjem
ferring gmbh, wittland 11, kiel, njemačka - budezonid - tableta s produljenim oslobađanjem - 9 mg - urbroj: jedna tableta sadrži 9 mg budezonida
symbicort turbuhaler 9 mcg/doza + 320 mcg/doza prašak za inhalaciju
druŠtvo za trgovinu na veliko farmaceutskim proizvodima "glosarij" d.o.o.-podgorica - formoterol, budesonid - prašak za inhalaciju - 9 mcg/doza + 320 mcg/doza
duoresp spiromax
teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - lijekovi za opstruktivne plućne bolesti dišnih putova, - asthma duoresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdduoresp spiromax is indicated in adults, aged 18 years and older for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).
biresp spiromax
teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - lijekovi za opstruktivne plućne bolesti dišnih putova, - asthma biresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdbiresp spiromax is indicated in adults, aged 18 years and older, for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).
jorveza
dr. falk pharma gmbh - budesonide - ezofagealne bolesti - antidiarrheal sredstva, uzročnika crijevnih protuupalnih / antiinfective - jorrava je indicirana za liječenje eozinofilnog esophagitis (eoe) kod odraslih osoba (starijih od 18 godina).
budosan 3 mg želučanootporne kapsule
dr. falk pharma gmbh, leinenweberstraße 5, freiburg, njemačka - budezonid - želučanootporna kapsula, tvrda - 3 mg - urbroj: svaka kapsula sadrži 3 mg budezonida
budelin novolizer 200 mikrograma/dozi prašak inhalata
viatris hrvatska d.o.o., koranska 2, zagreb, hrvatska - budezonid - prašak inhalata - 200 mikrograma - urbroj: jedna inhalacijska doza sadržava 200 mikrograma budezonida
symbicort turbuhaler 320 mikrograma/9 mikrograma po inhalaciji, prašak inhalata
astrazeneca d.o.o., radnička cesta 80, zagreb, hrvatska - budezonid formoterolfumarat dihidrat - prašak inhalata - 320 mikrograma + 9 mikrograma - urbroj: jedna inhalacijska doza sadrži 320 mikrograma budesonida i 9 mikrograma formoterolfumarat dihidrata
symbicort turbuhaler 80 mikrograma/4,5 mikrograma po inhalaciji, prašak inhalata
astrazeneca d.o.o., radnička cesta 80, zagreb, hrvatska - budezonid formoterolfumarat dihidrat - prašak inhalata - 80 mikrograma + 4,5 mikrograma - urbroj: jedna inhalacijska doza sadrži 80 mikrograma budesonida i 4,5 mikrograma formoterolfumarat dihidrata